VALENCIA, Calif., Jan. 27, 2016 (GLOBE NEWSWIRE) — Envoy Group Corp (OTC:ENVV) is pleased to announce the company has signed an exclusive agreement with BVD Ltd for the exclusive distribution rights for the Louis XIV Energy Drinks within Taiwan.
Presently, the Louis XIV’s unique line of energy drinks are only available in Europe. The sensational core line of Louis XIV products boasts four revolutionary, unique and vibrant energy drinks. Each Louis XIV product has an outstanding look and taste, which stands alone as a perfect refresher or as complementary mixer in a variety of cocktails.
Energy Drinks have seen tremendous growth in popularity and consumption by all age groups. According to BeverageDail.com the industry has now reached $50 Billion globally. The Asian energy drink beverage market is still growing in double digits and contains huge future growth potential.
Harp Sangha, Envoy’s CEO comments “We are delighted to be bringing the premium Louis XIV Energy Drink line to Taiwan. Taiwan is a large market and like the rest of the world energy drinks have taken the country by storm. This new market presents an enormous opportunity for our entire line of drinks. The Energy drink market is poised for further growth and Taiwan is a high density exciting growth market for our product.”
Harp further states, “Two of the leading three energy drink companies are privately owned, thus we hope investors who want exposure to this lucrative beverage market will see Envoy as a key company to watch in 2016. We feel the superior taste, advanced formula and the sophisticated look of the Louis XIV brand has exceptional consumer appeal and will gain prominence in the multi-billion dollar energy drink market.”
Envoy’s comprehensive marketing and distribution campaign is currently in the works and product roll out will commence as soon as regulatory measures are met.
Envoy Group website link http://envoygroupcorp.com/lxiv/
Louis XIV website link: http://www.louisxivenergy.com/en/
Stuart T. Smith:
Harp Sangha Chairman/CEO
Safe Harbor Statements
Certain information contained in this news release constitutes “forward-looking statements” as such term is used in applicable United States and Canadian laws. Generally, these forward-looking statements can be identified by the use of forward-looking terminology such as “expects” or “does not expect”, “is expected”, “anticipates” or “does not anticipate”, “plans”, “estimates”, “intends” or “believes”, or that certain actions, events or results “may”, “could”, “would”, “might” or “will be taken”, “occur”, or “be achieved”. Forward-looking statements are based on the opinions and estimates of management as of the date such statements are made, and are subject to known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of the Company to be materially different from those expressed or implied by such forward-looking statements. Many of these factors are beyond the Company’s ability to control or predict. Important factors that may cause actual results to differ materially and that could impact the Company and the statements contained in this news release can be found in the Company’s filings with the SEC. Such risks and other factors include, among others, the ability to locate and acquire suitable interests in alternative medicine manufacturing operations on terms acceptable to the Company, the availability of financing on acceptable terms, accidents, labor disputes, acts of God and other risks of the alternative medicine industry including, without limitation, delays in obtaining governmental approvals or permits, title disputes or claims limitations on insurance coverage. The Company believes that the expectations reflected in the forward-looking statements included in this news release are reasonable; however, no assurance can be given that these expectations will prove to be correct, and such forward-looking statements should not be unduly relied upon. The Company assumes no obligation to update or supplement any forward-looking statements whether as a result of new information, future events or otherwise.